Results 11 to 20 of about 45,912 (262)

Oral Cholera Vaccine Efficacy and Effectiveness. [PDF]

Vaccines (Basel), 2021
Song KR, Lim JK, Park SE, Saluja T, Cho SI, Wartel TA, Lynch J.   +6 more
europepmc   +3 more sources

Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023. [PDF]

Clin Infect Dis
Edosa M, Jeon Y, Gedefaw A, Hailu D, Mesfin Getachew E, Mogeni OD, Jang GH, Mukasa D, Yeshitela B, Getahun T, Lynch J, Bouhenia M, Worku Demlie Y, Hussen M, Wossen M, Teferi M, Park SE.   +16 more
europepmc   +3 more sources

Cost of oral cholera vaccine delivery in a mass immunization program for children in urban Bangladesh. [PDF]

Vaccine X, 2022
Sarker AR, Khan AI, Islam MT, Chowdhury F, Khanam F, Kang S, Ahmmed F, Im J, Kim DR, Tadesse BT, Ahmed T, Aziz AB, Hoque M, Park J, Liu X, Pak G, Zaman K, Marks F, Kim JH, Clemens JD, Qadri F.   +20 more
europepmc   +2 more sources

Cholera vaccines

, 2013
John D. Clemens, Sunheang Shin, Binod K. Sah, David A. Sack   +3 more
openaire   +2 more sources

Cholera Vaccines [PDF]

Journal of Travel Medicine, 2000
Cholera causes significant morbidity and mortality worldwide. For travelers, the risk of developing cholera per month of stay in a developing country is approximately 0.001%-0.01%, and cholera may present as traveler's diarrhea. In the United States, only a poorly tolerated, marginally effective, parenterally administered, phenol-inactivated vaccine is
E T, Ryan, S B, Calderwood
openaire   +4 more sources

Immunogenicity of cholera vaccination in children with inflammatory bowel disease

Human Vaccines & Immunotherapeutics, 2021
The cholera vaccine can protect patients with inflammatory bowel disease (IBD) against both cholera and travelers’ diarrhea. However, both immunosuppressive treatment and IBD can affect its vaccine immunogenicity.
Łukasz Dembiński, Anna Stelmaszczyk-Emmel, Katarzyna Sznurkowska, Agnieszka Szlagatys-Sidorkiewicz, Andrzej Radzikowski, Aleksandra Banaszkiewicz   +5 more
doaj   +1 more source

Assessment of Stability of Chemical Cholera Vaccine in a New Primary Packaging

Проблемы особо опасных инфекций, 2023
The bivalent chemical cholera vaccine is the only drug for the prevention of cholera registered in the Russian Federation. The vaccine has been produced in glass bottles containing 210 tablets.
O. V. Gromova, S. A. Vorob’eva, O. A. Volokh, O. D. Klokova, L. F. Livanova, N. I. Belyakova, E. Z. Popova, O. A. Lobovikova, I. V. Shul’gina, I. G. Shvidenko, A. K. Nikiforov   +10 more
doaj   +1 more source

Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. [PDF]

PLoS ONE, 2014
There is increasing interest to use oral cholera vaccination as an additional strategy to water and sanitation interventions against endemic and epidemic cholera.
Jacqueline Deen, Mohammad Ali, David Sack   +2 more
doaj   +1 more source

Cholera Vaccine

, 2006
europepmc   +2 more sources

IMPROVEMENT OF SPECIFIC CHOLERA PREVENTION USING IMMUNOMODULATORS

Медицинская иммунология, 2021
It is known that the combined use of vaccines, cytokines and various immunomodulatory drugs contributes to the development of a full-fledged immune response.
A. V. Filippenko, N. D. Omelchenko, N. I. Pasyukova, A. A. Trufanova, I. A. Ivanova   +4 more
doaj   +1 more source